Press release from Companies

Published: 2021-12-22 13:09:23

Polymer Factory Sweden AB: Polymer Factory Sweden AB launches a new product platform: BowtieD®

Polymer Factory Sweden AB today announces the launch of the new dendritic platform BowtieD®. Through the launch of these next generation dendritic products, the Company already reaches an operational objective set out for 2022.

BowtieD® is a platform consisting of bifunctional dendritic materials, meaning they can carry more than one functional group at its surface, through a bowtie structure. The materials are highly sophisticated and are built on strong scientific evidence. By launching BowtieD®, Polymer Factory becomes the first-in-world commercial provider of bifunctional dendrimers.

The BowtieD® platform will primarily target the big pharma, biotech, diagnostic and medtech markets. In 2021, prior to the official launch of the platform, the Company has already completed a customized bifunctional dendrimer for a global biotech company.

CTO Michael Malkoch comments:

"BowtieD® dendrimers are the pinnacle of polymer-based carriers for therapeutic, diagnostic applications and much more. The foundation of this class of dendrimers is resonated by their extraordinary features such as flawless structures, biodegradability, and multitude of two active sites that are bundled in a bow-tied configuration. Never before has such dendritic technology been commercially available and with this launch, I truly believe that Polymer Factory will move its position, globally, by providing customers with next generation carriers to address challenges in high-demanding life-science technologies."

Hear more from CTO Michael Malkoch in this video.

On December 22, 2021, three product families are launched under the trademark BowtieD®. Pricing start at €2,701 per gram, and the products are sold in 50, 100 and 250mg quantities.  

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.

Läs mer hos Cision
Read more about Polymer Factory Sweden AB

Subscription